Centre Flags Carcinogen Fears On Acidity Medicine Ranitidine, Orders Probe

The Central Drugs Standard Control Organisation (CDSCO) has directed all state and union territory drug regulators to ensure manufacturers of Ranitidine — a commonly used acidity medicine –monitor NDMA levels.

More From Author

Delhi Man, 42, Kills Colleague For Refusing Loan, Dumps Body In Tank: Cops

Credit cards race: Citi launches Strata Elite to rival AmEx Platinum, Chase Sapphire Reserve with $595 fee and travel perks

Leave a Reply

Your email address will not be published. Required fields are marked *